Baker Brothers Life Sciences LP, Director, 10% Owner at Kodiak Sciences Inc. (KOD), bought 404,186 shares at $52.11 ($20.9M) on 2020-09-24, disclosed to the SEC on 2020-09-24.
Open-market purchase of $20.9M KOD by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.72 | 779 | $39K | 0.2% |
| 2 | $49.72 | 10,983 | $546K | 2.6% |
| 3 | $49.72 | 10,983 | $546K | 2.6% |
| 4 | $50.15 | 36,647 | $1.8M | 8.8% |
| 5 | $50.15 | 2,601 | $130K | 0.6% |
| 6 | $50.15 | 2,601 |
| $130K |
| 0.6% |
| 7 | $50.15 | 36,647 | $1.8M | 8.8% |
| 8 | $51.98 | 22,361 | $1.2M | 5.6% |
| 9 | $51.98 | 22,361 | $1.2M | 5.6% |
| 10 | $51.98 | 1,587 | $82K | 0.4% |
| 11 | $51.98 | 1,587 | $82K | 0.4% |
| 12 | $51.97 | 1,120 | $58K | 0.3% |
| 13 | $51.97 | 80 | $4K | 0.0% |
| 14 | $51.97 | 1,120 | $58K | 0.3% |
| 15 | $52.40 | 10,467 | $548K | 2.6% |
| 16 | $52.40 | 743 | $39K | 0.2% |
| 17 | $52.40 | 10,467 | $548K | 2.6% |
| 18 | $52.44 | 74,381 | $3.9M | 18.7% |
| 19 | $52.44 | 74,381 | $3.9M | 18.7% |
| 20 | $52.44 | 5,278 | $277K | 1.3% |
| 21 | $52.44 | 5,278 | $277K | 1.3% |
| 22 | $51.41 | 306 | $16K | 0.1% |
| 23 | $51.41 | 4,306 | $221K | 1.1% |
| 24 | $51.41 | 4,306 | $221K | 1.1% |
| 25 | $52.11 | 29,327 | $1.5M | 7.3% |
| 26 | $52.11 | 29,327 | $1.5M | 7.3% |
| 27 | $52.11 | 2,081 | $108K | 0.5% |
| 28 | $52.11 | 2,081 | $108K | 0.5% |
| Total | $51.71 avg | 404,186 | $20.9M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |